pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Jan 19, 2026

    16
    ›Jan 24, 2026approval218d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval218d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval218d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval218d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval218d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval218d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval218d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval218d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval217d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026grant217d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Ovarian Steroid Mechanisms of Female Cannabis Use: Longitudinal and Experimen...Bedrocan BV

    DA grant. $54,538. PI: Anna Patterson

    full page →nih reporter ↗

    Week of Jan 26, 2026

    34
    ›Jan 26, 2026approval216d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval
    ← prev
    page 415 of 475
    next →
    216d ago
    BETAMETHASONE DIPROPIONATE — FDA approvalBETAMETHASONE DIPROPIONATE

    Sponsor: AUROBINDO PHARMA LTD. Form: CREAM. Route: TOPICAL

    full page →BETAMETHASONE DIPROPIONATE →fda approvals ↗
    ›Jan 26, 2026approval216d agoPALIPERIDONE — FDA approvalpaliperidone ER

    Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →paliperidone ER →fda approvals ↗
    ›Jan 26, 2026approval216d agoMETHYLPREDNISOLONE ACETATE — FDA approvalPFIZER INC

    Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 26, 2026approval216d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 26, 2026approval216d agoFINASTERIDE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval216d agoCHLORPROMAZINE HYDROCHLORIDE — FDA approvalCHLORPROMAZINE HYDROCHLORIDE

    Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

    full page →CHLORPROMAZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 26, 2026approval216d agoTRANEXAMIC ACID — FDA approvalHyloris Pharmaceuticals SA

    Sponsor: I 3 PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval216d agoDIFLUPREDNATE — FDA approvalDIFLUPREDNATE

    Sponsor: ALEMBIC. Form: EMULSION. Route: OPHTHALMIC

    full page →DIFLUPREDNATE →fda approvals ↗
    ›Jan 26, 2026approval216d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Jan 26, 2026approval216d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: ACCORD HLTHCARE. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Jan 26, 2026approval216d agoBUDESONIDE — FDA approvalbudesonide DR

    Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →budesonide DR →fda approvals ↗
    ›Jan 26, 2026approval216d agoQUIOFIC (FOLIC ACID) — FDA approvalfolic acid

    Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL

    full page →folic acid →fda approvals ↗
    ›Jan 26, 2026approval216d agoCUPRIC CHLORIDE — FDA approvalCUPRIC CHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →CUPRIC CHLORIDE →fda approvals ↗
    ›Jan 26, 2026grant216d agoFLORIDA INTERNATIONAL UNIVERSITY — CRISPR/dCas9-Targeted Histone Demethylation Interplays with DNA Repair to Con...

    NS grant. $1,319,674. PI: Prem P Chapagain

    full page →nih reporter ↗
    ›Jan 26, 2026grant216d agoEMORY UNIVERSITY — Neuromodulation of somato-sympathetic postganglionic activity after SCIEmory University

    NS grant. $234,750. PI: SHAWN HOCHMAN

    full page →nih reporter ↗
    ›Jan 27, 2026approval215d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Jan 27, 2026approval215d agoNOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MSD MERCK CO. Form: FOR SUSPENSION, DELAYED RELEASE. Route: ORAL

    full page →POSACONAZOLE →fda approvals ↗
    ›Jan 27, 2026approval215d agoTAPENTADOL HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →POSACONAZOLE →fda approvals ↗
    ›Jan 27, 2026approval215d agoFIDAXOMICIN — FDA approvalDificid

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →Dificid →fda approvals ↗
    ›Jan 27, 2026approval215d agoVYXEOS (CYTARABINE) — FDA approvalMeitheal Pharmaceuticals Inc

    Sponsor: JAZZ PHARMS THERAP. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoMESNA — FDA approvalRiconpharma LLC

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: NATCO. Form: TABLET. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 27, 2026approval215d agoPROPRANOLOL HYDROCHLORIDE — FDA approvalpropranolol hydrochloride ER

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →propranolol hydrochloride ER →fda approvals ↗
    ›Jan 27, 2026approval215d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

    Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

    full page →TRAVOPROST →fda approvals ↗
    ›Jan 27, 2026approval215d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

    Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

    full page →TRAVOPROST →fda approvals ↗
    ›Jan 27, 2026approval215d agoNOXAFIL (POSACONAZOLE) — FDA approvali3 Pharmaceuticals LLC

    Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoCAPECITABINE — FDA approvalArmas Pharmaceuticals Inc

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

    Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

    full page →vandetanib →fda approvals ↗
    ›Jan 27, 2026approval215d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →rifapentine →fda approvals ↗
    ›Jan 27, 2026approval215d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 27, 2026approval215d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: SUN PHARM INDS INC. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Jan 27, 2026approval215d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →POSACONAZOLE →fda approvals ↗
    $PFE27.96-0.21%
    $COLL25.35-4.12%
    $GKOS179.87-1.12%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $MRK148.35-0.80%
    $AMRX17.54-2.61%
    $GKOS179.87-1.12%